TY  - JOUR

T1  - NOVEL DRUG TARGETS TO AUGMENT TEMOZOLOMIDE SENSITIVITY IN HIGH-GRADE BRAIN TUMOURS

JO  - NEURO-ONCOLOGY

PY  - 2018/10/03

AU  - Carmell N

AU  - Brown S

AU  - Khamisy S

AU  - Collis S

ED  - 

VL  - 20

SP  - 346

EP  - 346

Y2  - 2024/12/22

ER  -